Clinical trial
A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With…
NCT00471159 · Pfizer, Industry · Withdrawn
Key facts
| NCT number | NCT00471159 |
|---|---|
| Title | A Study Of Docetaxel Or Docetaxel Plus PF-3512676 To Treat Patients With Advanced Breast Cancer. |
| Official title | A Randomized Phase 2 Clinical Trial Of Docetaxel With Or Without PF-3512676 As First-Line Treatment Of Patients With Advanced Breast Cancer |
| Lead sponsor | Pfizer, Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | docetaxel, PF-3512676 |
| Enrollment | 0 |
| Start date | Aug 1, 2007 |
| First posted | May 9, 2007 |
| Last update posted | May 4, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: